Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
Clinical trial NCT03444844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03444844
- Sponsor
- Five Eleven Pharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2020-10-27
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.